CDK16
Basic information
Region (hg38): X:47217860-47229997
Previous symbols: [ "PCTK1" ]
Links
Phenotypes
GenCC
Source:
- intellectual disability, autosomal dominant 40 (Limited), mode of inheritance: XLR
- intellectual disability, autosomal dominant 40 (Limited), mode of inheritance: XL
- X-linked complex neurodevelopmental disorder (Limited), mode of inheritance: XL
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CDK16 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 5 | |||||
missense | 20 | 21 | ||||
nonsense | 2 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 3 | 2 | 5 | |||
non coding | 8 | |||||
Total | 0 | 0 | 27 | 4 | 6 |
Variants in CDK16
This is a list of pathogenic ClinVar variants found in the CDK16 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
X-47218661-C-G | Likely benign (Apr 01, 2022) | |||
X-47218663-AG-A | CDK16-related disorder | Uncertain significance (Apr 21, 2023) | ||
X-47223121-A-G | CDK16-related disorder | Benign (Jun 11, 2019) | ||
X-47223136-C-T | Intellectual disability | Uncertain significance (Feb 04, 2020) | ||
X-47223151-C-T | not specified | Uncertain significance (Sep 16, 2021) | ||
X-47223217-C-G | not specified • CDK16-related disorder | Benign (May 14, 2015) | ||
X-47223234-G-A | not specified | Uncertain significance (Jan 23, 2023) | ||
X-47223273-C-T | not specified | Benign (Dec 01, 2014) | ||
X-47223288-A-G | not specified | Uncertain significance (Jan 24, 2024) | ||
X-47223553-T-G | not specified | Uncertain significance (Dec 21, 2022) | ||
X-47223642-G-A | not specified | Uncertain significance (May 04, 2022) | ||
X-47223706-G-A | not specified | Uncertain significance (Mar 02, 2023) | ||
X-47223750-T-C | CDK16-related disorder | Uncertain significance (Sep 12, 2024) | ||
X-47224391-T-C | Uncertain significance (Oct 01, 2020) | |||
X-47224399-G-A | not specified | Uncertain significance (Apr 16, 2024) | ||
X-47224480-C-T | not specified | Uncertain significance (Jul 19, 2023) | ||
X-47224489-A-G | not specified | Uncertain significance (Aug 21, 2023) | ||
X-47224501-C-G | not specified | Uncertain significance (Dec 09, 2023) | ||
X-47224633-C-T | CDK16-related disorder | Likely benign (Sep 19, 2019) | ||
X-47224638-A-G | CDK16-related disorder | Benign (Jun 11, 2019) | ||
X-47224642-C-T | Uncertain significance (Mar 01, 2022) | |||
X-47224742-T-A | not specified | Uncertain significance (Apr 20, 2023) | ||
X-47224750-A-T | Benign (Sep 17, 2018) | |||
X-47225031-A-C | not specified | Uncertain significance (Apr 07, 2022) | ||
X-47225864-C-T | Uncertain significance (May 20, 2013) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CDK16 | protein_coding | protein_coding | ENST00000276052 | 16 | 12138 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.995 | 0.00520 | 123854 | 0 | 1 | 123855 | 0.00000404 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.91 | 122 | 252 | 0.484 | 0.0000222 | 3673 |
Missense in Polyphen | 27 | 106.58 | 0.25334 | 1595 | ||
Synonymous | 1.32 | 84 | 101 | 0.833 | 0.00000864 | 1183 |
Loss of Function | 4.20 | 2 | 24.4 | 0.0819 | 0.00000217 | 346 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000722 | 0.0000545 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.0000722 | 0.0000545 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Protein kinase that plays a role in vesicle-mediated transport processes and exocytosis. Regulates GH1 release by brain neurons. Phosphorylates NSF, and thereby regulates NSF oligomerization. Required for normal spermatogenesis. Regulates neuron differentiation and dendrite development (By similarity). Plays a role in the regulation of insulin secretion in response to changes in blood glucose levels. Can phosphorylate CCNY at 'Ser- 336' (in vitro). {ECO:0000250, ECO:0000269|PubMed:22184064, ECO:0000269|PubMed:22796189, ECO:0000269|PubMed:22798068}.;
Recessive Scores
- pRec
- 0.150
Intolerance Scores
- loftool
- 0.370
- rvis_EVS
- 0.08
- rvis_percentile_EVS
- 60.09
Haploinsufficiency Scores
- pHI
- 0.330
- hipred
- Y
- hipred_score
- 0.701
- ghis
- 0.538
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.539
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cdk16
- Phenotype
- cellular phenotype; endocrine/exocrine gland phenotype; reproductive system phenotype;
Gene ontology
- Biological process
- protein phosphorylation;exocytosis;spermatogenesis;growth hormone secretion;neuron projection development;regulation of cell cycle;regulation of insulin secretion involved in cellular response to glucose stimulus
- Cellular component
- nucleus;cytoplasm;cytosol;plasma membrane;synaptic vesicle;microtubule cytoskeleton;cell junction;extrinsic component of cytoplasmic side of plasma membrane;neuron projection
- Molecular function
- protein serine/threonine kinase activity;cyclin-dependent protein serine/threonine kinase activity;protein binding;ATP binding